rs769501271
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032926.3(TCEAL3):c.94G>A(p.Glu32Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000826 in 1,210,114 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032926.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCEAL3 | ENST00000372627.10 | c.94G>A | p.Glu32Lys | missense_variant | Exon 3 of 3 | 1 | NM_032926.3 | ENSP00000361710.5 | ||
TCEAL3 | ENST00000243286.7 | c.94G>A | p.Glu32Lys | missense_variant | Exon 3 of 3 | 1 | ENSP00000243286.3 | |||
TCEAL3 | ENST00000372628.5 | c.94G>A | p.Glu32Lys | missense_variant | Exon 3 of 3 | 5 | ENSP00000361711.1 | |||
TCEAL3 | ENST00000477014.1 | n.158+485G>A | intron_variant | Intron 2 of 6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000892 AC: 1AN: 112119Hom.: 0 Cov.: 23 AF XY: 0.0000292 AC XY: 1AN XY: 34287
GnomAD3 exomes AF: 0.00000550 AC: 1AN: 181790Hom.: 0 AF XY: 0.0000150 AC XY: 1AN XY: 66580
GnomAD4 exome AF: 0.00000820 AC: 9AN: 1097995Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 2AN XY: 363395
GnomAD4 genome AF: 0.00000892 AC: 1AN: 112119Hom.: 0 Cov.: 23 AF XY: 0.0000292 AC XY: 1AN XY: 34287
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.94G>A (p.E32K) alteration is located in exon 3 (coding exon 1) of the TCEAL3 gene. This alteration results from a G to A substitution at nucleotide position 94, causing the glutamic acid (E) at amino acid position 32 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at